|
|
Cytonome's proprietary technology – an ultra-high throughput, clinical-grade optical cell sorter – is the only optical sorting method with a fully closed, sterile and disposable fluidic path. Cytonome has sole ownership of a cluster of technologies protected by 17 issued patents along with 20 US applications pending, and 3 international patents issued along with 75 corresponding international filings. The patents cover high-velocity fluidic switch designs, microfluidic inline velocity measurement techniques, parallel sorting techniques, architectures and methods, and critical manufacturing processes.
|
